Come up with a name for your new list and we'll add to it:
SynphaBase raised a round of funding on , . Investors include
Novartis Venture Funds.
SynphaBase offers custom-synthesis of life science intermediate products obtained by synthetic and bioorganic methods, including chiral building blocks, amino and hydroxyl carbonic acids and peptides/…